Nox4 in renal diseases: An update

被引:93
|
作者
Yang, Qin [1 ]
Wu, Fan-rong [1 ]
Wang, Jia-nan [1 ]
Gao, Li [1 ]
Jiang, Ling [1 ]
Li, Hai-Di [1 ]
Ma, Qiuying [1 ]
Liu, Xue-qi [1 ]
Wei, Biao [1 ]
Zhou, Luyu [1 ]
Wen, Jiagen [1 ,2 ,3 ]
Ma, Tao Tao [1 ,2 ,3 ]
Li, Jun [1 ,2 ,3 ]
Meng, Xiao-ming [1 ,2 ,3 ]
机构
[1] Anhui Med Univ, Sch Pharm, Hefei, Anhui, Peoples R China
[2] Anhui Inst Innovat Drugs, Hefei, Anhui, Peoples R China
[3] Minist Educ, Key Lab Antiinflammatory & Immune Med, Hefei 230032, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
Reactive oxygen species; NADPH oxidases 4; Fibrosis; Inflammation; apoptosis; NADPH OXIDASE 4; ACUTE KIDNEY INJURY; ANGIOTENSIN-II; NAD(P)H OXIDASE; FIBRONECTIN EXPRESSION; DIABETIC-NEPHROPATHY; DEPENDENT REGULATION; OXIDATIVE STRESS; UP-REGULATION; MOUSE MODEL;
D O I
10.1016/j.freeradbiomed.2018.06.042
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Reactive oxygen species derived from NADPH oxidase contribute to a wide variety of renal diseases. Nox4, the major NADPH isoform in kidney, produces mainly H2O2 that regulates physiological functions. Nox4 contributes to redox processes involved in diabetic nephropathy, acute kidney injury, obstructive nephropathy, hypertensive nephropathy, renal cell carcinoma and other renal diseases by activating multiple signaling pathways. Although Nox4 is found in a variety of cell types, including epithelial cells, podocytes, mesangial cells, endothelial cells and fibroblasts, its role is not clear and even controversial. In some conditions, Nox4 protects cells by promoting cell survival in response to harmful stimuli. In other scenarios it induces cell apoptosis, inflammation or fibrogenesis. This functional variability may be attributed to distinct cell types, subcellular localization, molecular concentrations, disease type or stage, and other factors yet unexplored. In this setting, we reviewed the function and mechanism of Nox4 in renal diseases, highlighted the contradictions in Nox4 literature, and discussed promising therapeutic strategies targeting Nox4 in the treatment of certain types of renal diseases.
引用
收藏
页码:466 / 472
页数:7
相关论文
共 50 条
  • [1] The role of NOX4 in pulmonary diseases
    Li, Zi-Ming
    Xu, Sheng-Ya
    Feng, Yi-Zhuo
    Cheng, Yu-Rui
    Xiong, Jian-Bing
    Zhou, Yong
    Guan, Cha-Xiang
    JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (03) : 1628 - 1637
  • [2] Nox5 A: ravates Renal Injury Independent of Nox4 Expression in Diabetes
    Jha, Jay C.
    Urner, Sofia
    Dai, Aozhi
    Cooper, Mark E.
    Roden, Michael
    Kennedy, Chris
    Jandeleit-Dahm, Karin
    DIABETES, 2020, 69
  • [3] NADPH oxidase 4 (NOX4) as a biomarker and therapeutic target in neurodegenerative diseases
    Napissara Boonpraman
    Sun Shin Yi
    Neural Regeneration Research, 2024, 19 (09) : 1961 - 1966
  • [4] NADPH oxidase 4 (NOX4) as a biomarker and therapeutic target in neurodegenerative diseases
    Boonpraman, Napissara
    Yi, Sun Shin
    NEURAL REGENERATION RESEARCH, 2024, 19 (09) : 1961 - 1966
  • [5] Silencing of Nox4 enhances cisplatin chemosensitivity of renal cell carcinoma
    Maranchie, Jodi K.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 37 - 37
  • [6] Cardiovascular protection by Nox4
    Morawietz, Henning
    CARDIOVASCULAR RESEARCH, 2018, 114 (03) : 353 - 355
  • [7] Expression of Nox4 in osteoclasts
    Yang, S
    Zhang, YZ
    Ries, W
    Key, L
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 92 (02) : 238 - 248
  • [8] Human nox4 overexpression in rat vascular adventitial myofibroblasts inhibits endogenous nox4
    Haurani, Mounir J.
    Cifuentes, M. E.
    Pagano, Patrick J.
    HYPERTENSION, 2007, 50 (04) : E105 - E105
  • [9] Is NOX5 potentially a better therapeutic target than NOX4 in renal complications of diabetes?
    Jha, J.
    L-Trevino, S.
    Dai, A.
    Vincent, J.
    Meister, J.
    Cooper, M. E.
    Jandeleit-Dahm, K.
    DIABETOLOGIA, 2024, 67 : S106 - S106
  • [10] Redox Control of Renal Metabolism and Transport Function by the NADPH Oxidase Nox4
    Rezende, Flavia
    Loewe, Oliver
    Mueller, Niklas
    Malacarne, Pedro Felipe
    Pfitzner, Maik
    Walter, Maria
    Zukunft, Sven
    Fleming, Ingrid
    Brandes, Ralf
    Schroeder, Katrin
    FREE RADICAL BIOLOGY AND MEDICINE, 2017, 112 : 174 - 174